Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Higher IL-17A levels indicate more severe alopecia areata.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Intralesional triamcinolone acetonide is preferred for treating patchy alopecia areata due to fewer side effects.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Upadacitinib improved multiple immune-related conditions in one patient.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Injecting vitamin D3 into the skin is an effective treatment for patchy hair loss.